These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22386588)

  • 1. Historical review, epidemiology and natural history of degenerative mitral valve disease.
    Borgarelli M; Buchanan JW
    J Vet Cardiol; 2012 Mar; 14(1):93-101. PubMed ID: 22386588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
    Aupperle H; Disatian S
    J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of myxomatous mitral valve disease in the dog.
    Fox PR
    J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of myxomatous mitral valve disease in dogs.
    Atkins CE; Häggström J
    J Vet Cardiol; 2012 Mar; 14(1):165-84. PubMed ID: 22386553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease.
    Häggström J; Höglund K; Borgarelli M
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():25-33. PubMed ID: 19765217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of innervation of the mitral valves and the effects of myxomatous degeneration in dogs.
    Culshaw GJ; French AT; Han RI; Black A; Pearson GT; Corcoran BM
    Am J Vet Res; 2010 Feb; 71(2):194-202. PubMed ID: 20113227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA
    J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
    Beardow AW; Buchanan JW
    J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.
    Borgarelli M; Haggstrom J
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):651-63. PubMed ID: 20610017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral valve degeneration: still more questions than answers.
    Orton EC
    J Vet Cardiol; 2012 Mar; 14(1):3-5. PubMed ID: 22366567
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
    Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
    J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holter monitoring in 36 dogs with myxomatous mitral valve disease.
    Crosara S; Borgarelli M; Perego M; Häggström J; La Rosa G; Tarducci A; Santilli RA
    Aust Vet J; 2010 Oct; 88(10):386-92. PubMed ID: 20854294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasma and urinary levels of 6-keto-prostaglandin F1alpha as a marker for asymptomatic myxomatous mitral valve disease in dogs.
    Rasmussen CE; Sundqvist AV; Kjempff CT; Tarnow I; Kjelgaard-Hansen M; Kamstrup TS; Sterup AL; Soerensen TM; Olsen LH
    Vet J; 2010 May; 184(2):241-6. PubMed ID: 19324577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
    Hezzell MJ; Boswood A; Moonarmart W; Elliott J
    J Vet Cardiol; 2012 Mar; 14(1):269-79. PubMed ID: 22366569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of mitral valve insufficiency in cavalier King Charles spaniels.
    Malik R; Hunt GB; Allan GS
    Vet Rec; 1992 Apr; 130(14):302-3. PubMed ID: 1595150
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of signal analysis of heart sounds and murmurs to assess severity of mitral valve regurgitation attributable to myxomatous mitral valve disease in dogs.
    Ljungvall I; Ahlstrom C; Höglund K; Hult P; Kvart C; Borgarelli M; Ask P; Häggström J
    Am J Vet Res; 2009 May; 70(5):604-13. PubMed ID: 19405899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into degenerative mitral valve disease in dogs.
    Häggström J; Duelund Pedersen H; Kvart C
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1209-26, vii-viii. PubMed ID: 15325478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.
    Brüler BC; Jojima FS; Dittrich G; Giannico AT; Sousa MG
    J Vet Cardiol; 2018 Aug; 20(4):254-266. PubMed ID: 30031743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.